Silence Therapeutics PLC (SLN) — Free Cash Flow Generation Index
Silence Therapeutics PLC (SLN) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of $1.49 Million represents 1% of operating cash flow ($1.49 Million). Explore Silence Therapeutics PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Silence Therapeutics PLC Free Cash Flow Generation Index (2019–2021)
Historical FCF Generation Index trend for Silence Therapeutics PLC across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Silence Therapeutics PLC.
Annual Free Cash Flow Generation for Silence Therapeutics PLC (2019–2021)
Year-by-year Free Cash Flow Generation Index for Silence Therapeutics PLC. Check Silence Therapeutics PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | $7.39 Million | $9.19 Million | $1.80 Million | ▼ -19.2% |
| 2019 | 0.99x | $1.72 Million | $1.73 Million | $9.00K | — |